"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sable told CNBC in an ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Pete Giacchi, Citadel Securities, joins 'Money Movers' to discuss Venture Global's initial public offering, the biggest IPO ...

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...

Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...

Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial ...

Energy company Venture Global prices 70 million shares at $25 — the middle of its reduced $23-$27 price range.

When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

The IPO consists of fresh issue of shares worth up to 15 billion rupees, while existing shareholder Menon Family Holdings ...

The San Diego–based company’s molecules avoid the well-trod GLP-1 pathway in favor of an alternate route in the gut.